SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Stock Swap -- Ignore unavailable to you. Want to Upgrade?


To: Tech Master who wrote (16874)12/15/1999 4:25:00 PM
From: Andrew Vance  Read Replies (1) | Respond to of 17305
 
*AV*--Gee whiz, where were you on Monday when it jumped to $1.50? <GGG> Now I am too nervous to chase it at its 52 week high on little news this past week. Sounds like some behind the scenes stuff is going on. My brother has some of this stock since he dabbles in Biotech stuff more than I do.

If he is any judge of successful stocks I would watch this very carefully. His track record has been poor, but his take on the biotech drug situation is that you kiss alot of frogs before your princess appears, making all the frog kissing worthwhile<GGG>. He has been on a horrific losing streak lately so this may be the princess for him. I will give him a call and check in. Who knows, the rise could be due to his finally exiting his position.<GGG>

As for me, my biotech holdings are heavyweight AMGN and fly in the pie and in my face<g> NPRO. Thankfully NPRO is a ~$1 entry and we are up. But it has failed to make the cancer drug rocket type appreciation for its drug as I expected.

You never know, I am frustrated enough that I might have split the pain between CELN and NPRO at $1.50 and been a happy camper<GGG>. At current levels I am inclined to look for a slight pullback if it occurs. However, since my timing on small Biotech stocks could be considered one of the most pathetic by any investor, if I buy CELN, it will crater the stock. If I watch it, CELN will shoot to the moon. Actually my most profitable biotech investment was ENMD with almost all of it coming from the short side<GGG>. Even that was a negative biotech situation.

So, I will watch and salivate. But when CELN hits $15, you owe me big time for not jinxing the stock by investing in it.<GGG> All gratuities for that service would be gladly accpeted<GGGG>.

AV